Professor Papa has developed an expertise in engineering novel therapeutic platforms at the interface of chemistry, biology, and medicine. She focuses her work on disease processes, particularly in cancer and vascular diseases, toward the goal of designing targeted translational therapies and new diagnostic methods. Her research is based on understanding system interactions (i.e. cell-cell and cell-particle) and delivery platforms (particle-based targeting strategies as well as cellular therapeutics). Her lab is geared to using this knowledge to identify both therapy-related and disease-related factors that can be used in a synergistic way to maximize the potential of these novel approaches.